Cresco Labs Inc. engages in cultivating medical grade cannabis, manufacturing medical products derived from cannabis cultivation, and distributing such products to medical or adult use consumers. The company is headquartered in Chicago, Illinois and currently employs 2,900 full-time employees. The company went IPO on 2018-12-03. The firm is licensed to cultivate, manufacture, and sell retail and medical cannabis products primarily through Sunnyside, Cresco Labs’ national dispensary brand, and third-party retail stores. Its family brands include Cresco, High Supply, Good News, Wonder Wellness Co., FloraCal Farms, Remedi and Mindy’s. Its portfolio consists of over 500 products. Its products are sold in over 1,400 dispensaries across the country. Cresco offers flower, liquid live resin vapes and concentrates available in a variety of product forms at dispensaries and retail locations. Its High Supply is lab-tested, and available in vape carts, vape pens, flowers, popcorn, shakes, shorties, and concentrates. Its Remedi products provide a consistent and trusted alternative to traditional pharmaceuticals like opioids. Mindy’s offers dosed edibles created by James Beard. The company is the wholesaler of branded cannabis products.

Industry: Medicinal Chemicals & Botanical Products Peers: Amphastar Pharmaceuticals, Inc. Amylyx Pharmaceuticals Inc CinCor Pharma, Inc. Johnson & Johnson NGM BIOPHARMACEUTICALS INC Revance Therapeutics, Inc. Supernus Pharmaceuticals Inc Tilray Brands Inc